Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Abnova Investor Presentation 2020

Sep 22, 2020

52384_rns_2020-09-22_c0608b75-7a3d-467a-9ab8-83bfd039296a.pdf

Investor Presentation

Open in viewer

Opens in your device viewer

==> picture [794 x 119] intentionally omitted <==

==> picture [794 x 359] intentionally omitted <==

1

免責聲明

本簡報及同時發佈之相關訊息包含財務、市場暨產品業務等預測性 資訊。本公司未來實際發生的營運結果及財務狀況可能與這些預測性資 訊所明示或暗示的預估有所差異,其原因可能來自於各種本公司所不能 掌控的風險。這些預估及展望的訊息,反應本公司截至目前為止對於未 來的看法,本公司並不負責隨時提醒或更新。

2

議程

公司簡介

  • 2020年第二季&上半年財務成果

亞諾法COVID‐19產品說明

Q&A

==> picture [794 x 120] intentionally omitted <==

3

==> picture [794 x 119] intentionally omitted <==

==> picture [794 x 121] intentionally omitted <==

==> picture [794 x 120] intentionally omitted <==

I. 亞諾法公司簡介

4

亞諾法公司簡介

==> picture [794 x 359] intentionally omitted <==

5

2020年第二季及上半年合併損益表

In NT$K

Q2‘20 % Q2‘19 % H1‘20 % H1‘19 % H1 YOY
營業收入 103,319 100% 103,591 100.00% 203,229 100.00% 212,172 100.00% (4.21%)
營業成本 (56,609) (54.79%) (59,721) (57.7%) (110,523) (54.38%) (125,624) (59.2%) (12.02%)
營業毛利 46,710 45.21% 43,870 42.3% 92,706 45.62% 86,548 40.8% 7.12%
營業費用 (38,309) (37.08%) (45,306) (43.7%) (77,020) (38.90%) (90,616) (42.7%) (15.00%)
營業利益 8,401 8.13% (1,436) (1.4%) 15,686 6.72% (4,068) (1.9%) 485.59%
營業外收入及支出 (3,009) (2.91%) 2,374 2.3% (900) (1.44%) 3,133 1.5% (128.73%)
稅前淨利 5,392 5.22% 938 0.9% 14,786 6.28% (935) (0.4%) 1681.39%
稅後淨利 4,122 3.99% 2,503 2.4% 11,818 4.82% 634 0.3% 1764.04%
基本每股盈餘 0.07 0.04 0.2 0.01

6

產品別營收分析

==> picture [794 x 359] intentionally omitted <==

----- Start of picture text -----

In NT$K
2020 Jan-Aug
450,000
400,000
101,562
350,000
300,000 21%
64,473
61,959
250,000
Antibody
49,215
200,000 50% Protein
36,224 Others
150,000
17%
248,123 COVID-19 related
100,000
146,651
50,000
12%
0
2019 2020 Jan-Aug
----- End of picture text -----

抗體 蛋白質 其他 COVID-19 相關

7

==> picture [794 x 119] intentionally omitted <==

==> picture [794 x 359] intentionally omitted <==

8

==> picture [794 x 119] intentionally omitted <==

==> picture [794 x 121] intentionally omitted <==

==> picture [794 x 120] intentionally omitted <==

II. 亞諾法 COVID‐19 產品

9

COVID‐19 自動化RNA 萃取系統

==> picture [794 x 121] intentionally omitted <==

==> picture [794 x 120] intentionally omitted <==

==> picture [670 x 170] intentionally omitted <==

10

抗體快速檢測試劑 COVID‐19 IgM IgG

  • 快速, 便利, 可靠

  • 15 分鐘即可獲得結果

  • 操作簡易

  • 結果可直接清楚辨識

指尖血檢測

==> picture [276 x 124] intentionally omitted <==

CE IVD Approved

==> picture [794 x 120] intentionally omitted <==

11

酵素免疫分析試劑組 COVID‐19 IgM IgG

COVID-19 IgM IgG 酵素免疫分析試劑組係利用檢測血清中IgM及IgG抗體 之定性檢測

12

COVID‐19 抗原快速檢測試劑 (Pending)

==> picture [598 x 307] intentionally omitted <==

13

COVID‐19 病毒抗原酵素免疫分析試劑組

Sandwich enzyme‐linked immunosorbent assays for the quantitative measurement of COVID‐19 viral or . spike antigen nucleocapsid antigen

COVID‐19 Viral Antigen S ELISA Kit COVID‐19 Viral Antigen N ELISA Kit (S棘醣蛋白) (N核蛋白)

==> picture [794 x 120] intentionally omitted <==

14

COVID‐19 中和性抗體檢測

==> picture [794 x 415] intentionally omitted <==

----- Start of picture text -----

Serum Pseudovirus
Spike protein
Pseudovirus infected and cells
expressed luciferase
Neutralized
----- End of picture text -----

==> picture [174 x 18] intentionally omitted <==

----- Start of picture text -----

Pseudovirus/Antibody
----- End of picture text -----

==> picture [95 x 12] intentionally omitted <==

----- Start of picture text -----

293T‐ACE2 cell
----- End of picture text -----

Without luciferase expression

15

COVID‐19 治療性抗體

(A) Antibody with Spike protein

==> picture [102 x 179] intentionally omitted <==

==> picture [105 x 120] intentionally omitted <==

----- Start of picture text -----

Antibody
Spike protein
----- End of picture text -----

(B) Antibody with Pseudovirus

==> picture [295 x 179] intentionally omitted <==

==> picture [385 x 225] intentionally omitted <==

----- Start of picture text -----

Flow cytometer analysis
Neutralized Non‐neutralized
Mouse IgG
----- End of picture text -----

==> picture [397 x 199] intentionally omitted <==

----- Start of picture text -----

Luciferase activity assay
----- End of picture text -----

3株候選抗體已有1株完成人類化

16

技術開發COVID-19疫苗 Self‐Amplifying mRNA (Pending)

==> picture [699 x 297] intentionally omitted <==

==> picture [699 x 149] intentionally omitted <==

17

==> picture [794 x 119] intentionally omitted <==

==> picture [794 x 121] intentionally omitted <==

==> picture [794 x 120] intentionally omitted <==

==> picture [794 x 120] intentionally omitted <==

18